UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 10-Q
(Mark One)
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended June 30, 2012
or
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from to
Commission file number: 000-10030
APPLE INC.
(Exact name of Registrant as specified in its charter)
California
94-2404110
(State or other jurisdiction
of incorporation or organization)
(I.R.S. Employer Identification No.)
1 Infinite Loop
Cupertino, California
95014
(Address of principal executive offices)
(Zip Code)
Registrant s telephone number, including area code: (408) 996-1010
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the
Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
Yes No
Indicate by check mark whether the registrant has submitted electronically
and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T ( 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the
registrant was required to submit and post such files).
Yes No
Indicate by check mark whether the registrant is a large accelerated filer,
an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of large accelerated filer, accelerated filer and smaller reporting company in Rule 12b-2 of the Exchange Act.
Large accelerated filer
Accelerated filer
Non-accelerated filer
(Do not check if a smaller reporting company)
Smaller reporting company
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).
Yes No
937,406,000 shares of common stock issued and outstanding as of July 13, 2012
PART I. FINANCIAL INFORMATION
Item 1.
Financial Statements
APPLE INC.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited)
(in millions, except number of shares which are reflected in thousands and per share amounts)
Three Months Ended
Nine Months Ended
June 30,
2012
June 25,
2011
June 30,
2012
June 25,
2011
Net sales
35,023
28,571
120,542
79,979
Cost of sales
20,029
16,649
66,281
47,541
Gross margin
14,994
11,922
54,261
32,438
Operating expenses:
Research and development
876
628
2,475
1,784
Selling, general and administrative
2,545
1,915
7,489
5,574
Total operating expenses
3,421
2,543
9,964
7,358
Operating income
11,573
9,379
44,297
25,080
Other income and expense
288
172
573
334
Income before provision for income taxes
11,861
9,551
44,870
25,414
Provision for income taxes
3,037
2,243
11,360
6,115
Net income
8,824
7,308
33,510
19,299
Earnings per common share:
Basic
9.42
7.89
35.89
20.91
Diluted
9.32
7.79
35.48
20.63
Shares used in computing earnings per share:
Basic
936,596
926,108
933,672
922,917
Diluted
947,059
937,810
944,440
935,688
See accompanying Notes to Condensed Consolidated Financial Statements.
APPLE INC.
CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited)
(in millions, except number of shares which are reflected in thousands)
June 30,
2012
September 24,
2011
ASSETS:
Current assets:
Cash and cash equivalents
7,945
9,815
Short-term marketable securities
19,709
16,137
Accounts receivable, less allowances of $94 and $53, respectively
7,657
5,369
Inventories
1,122
776
Deferred tax assets
2,309
2,014
Vendor non-trade receivables
6,641
6,348
Other current assets
6,560
4,529
Total current assets
51,943
44,988
Long-term marketable securities
89,567
55,618
Property, plant and equipment, net
10,487
7,777
Goodwill
1,132
896
Acquired intangible assets, net
4,329
3,536
Other assets
5,438
3,556
Total assets
162,896
116,371
LIABILITIES AND SHAREHOLDERS EQUITY:
Current liabilities:
Accounts payable
16,808
14,632
Accrued expenses
10,430
9,247
Deferred revenue
5,822
4,091
Total current liabilities
33,060
27,970
Deferred revenue non-current
2,530
1,686
Other non-current liabilities
15,560
10,100
Total liabilities
51,150
39,756
Commitments and contingencies
Shareholders equity:
Common stock, no par value; 1,800,000 shares authorized; 937,266 and 929,277 shares issued and outstanding,
respectively
15,573
13,331
Retained earnings
95,641
62,841
Accumulated other comprehensive income
532
443
Total shareholders equity
111,746
76,615
Total liabilities and shareholders equity
162,896
116,371
See accompanying Notes to Condensed Consolidated Financial Statements.
APPLE INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)
(in millions)
Nine Months Ended
June 30,
2012
June 25,
2011
Cash and cash equivalents, beginning of the period
9,815
11,261
Operating activities:
Net income
33,510
19,299
Adjustments to reconcile net income to cash generated by operating activities:
Depreciation, amortization and accretion
2,296
1,271
Share-based compensation expense
1,292
870
Deferred income tax expense
4,066
2,232
Changes in operating assets and liabilities:
Accounts receivable, net
(2,278
(592
Inventories
(346
162
Vendor non-trade receivables
(293
(955
Other current and non-current assets
(3,238
(1,551
Accounts payable
2,450
2,480
Deferred revenue
2,575
1,276
Other current and non-current liabilities
1,686
2,608
Cash generated by operating activities
41,720
27,100
Investing activities:
Purchases of marketable securities
(121,091
(75,133
Proceeds from maturities of marketable securities
10,344
16,396
Proceeds from sales of marketable securities
73,140
34,301
Payments made in connection with business acquisitions, net of cash acquired
(350
Payments for acquisition of property, plant and equipment
(4,834
(2,615
Payments for acquisition of intangible assets
(1,067
(266
Other
(56
34
Cash used in investing activities
(43,914
(27,283
Financing activities:
Proceeds from issuance of common stock
433
577
Excess tax benefits from equity awards
1,036
915
Taxes paid related to net share settlement of equity awards
(1,145
(479
Cash generated by financing activities
324
1,013
(Decrease)/increase in cash and cash equivalents
(1,870
830
Cash and cash equivalents, end of the period
7,945
12,091
Supplemental cash flow disclosure:
Cash paid for income taxes, net
5,901
2,563
See accompanying Notes to Condensed Consolidated Financial Statements.
Apple Inc.
Notes to Condensed Consolidated Financial Statements (Unaudited)
Note 1 Summary of Significant Accounting Policies
Apple Inc. and its wholly-owned subsidiaries (collectively Apple or the Company ) designs,
manufactures, and markets mobile communication and media devices, personal computers, and portable digital music players, and sells a variety of related software, services, peripherals, networking solutions, and third-party digital content and
applications. The Company sells its products worldwide through its retail stores, online stores, and direct sales force, as well as through third-party cellular network carriers, wholesalers, retailers and value-added resellers. In addition, the
Company sells a variety of third-party iPhone, iPad, Macintosh ( Mac ), and iPod compatible products including application software and various accessories through its online and retail stores. The Company sells to consumers, small and
mid-sized businesses, and education, enterprise and government customers.
Basis of Presentation and Preparation
The accompanying condensed consolidated financial statements include the accounts of the Company. Intercompany accounts and transactions
have been eliminated. The preparation of these condensed consolidated financial statements in conformity with U.S. generally accepted accounting principles ( GAAP ) requires management to make estimates and assumptions that affect the
amounts reported in these condensed consolidated financial statements and accompanying notes. Actual results could differ materially from those estimates. Prior period costs associated with the Company s high-profile retail stores have been
reclassified to conform to the current period s presentation. Refer to Note 7, Segment Information and Geographic Data, of this Form 10-Q.
These condensed consolidated financial statements and accompanying notes should be read in conjunction with the Company s annual consolidated financial statements and the notes thereto for the fiscal
year ended September 24, 2011, included in its Annual Report on Form 10-K (the 2011 Form 10-K ). The Company s fiscal year is the 52 or 53-week period that ends on the last Saturday of September. The Company s fiscal year
2012 will include 53-weeks and ends on September 29, 2012. An additional week has been included in the first quarter of 2012 to realign the Company s fiscal quarters more closely to calendar quarters. Unless otherwise stated, references to
particular years or quarters refer to the Company s fiscal years ended in September and the associated quarters of those fiscal years.
Earnings Per Common Share
Basic earnings per common share is computed by dividing income available to common shareholders by the weighted-average number of shares
of common stock outstanding during the period. Diluted earnings per common share is computed by dividing income available to common shareholders by the weighted-average number of shares of common stock outstanding during the period increased to
include the number of additional shares of common stock that would have been outstanding if the potentially dilutive securities had been issued. Potentially dilutive securities include outstanding stock options, shares to be purchased under the
Company s employee stock purchase plan and unvested restricted stock units ( RSUs ). The dilutive effect of potentially dilutive securities is reflected in diluted earnings per common share by application of the treasury stock method.
Under the treasury stock method, an increase in the fair market value of the Company s common stock can result in a greater dilutive effect from potentially dilutive securities.
The following table shows the computation of basic and diluted earnings per common share for
the three- and nine-month periods ended June 30, 2012 and June 25, 2011 (in thousands, except net income in millions and per share amounts):
Three Months Ended
Nine Months Ended
June 30,
2012
June 25,
2011
June 30,
2012
June 25,
2011
Numerator:
Net income
8,824
7,308
33,510
19,299
Denominator:
Weighted-average shares outstanding
936,596
926,108
933,672
922,917
Effect of dilutive securities
10,463
11,702
10,768
12,771
Weighted-average diluted shares
947,059
937,810
944,440
935,688
Basic earnings per common share
9.42
7.89
35.89
20.91
Diluted earnings per common share
9.32
7.79
35.48
20.63
The number of potentially dilutive securities excluded from the computation of diluted earnings per
common share because their effect would have been antidilutive was not significant for the three- and nine-month periods ended June 30, 2012 and June 25, 2011.
Fair Value Measurements
Fair value is the price that would be received
from selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Fair value is estimated by applying the following hierarchy, which prioritizes the inputs used to measure fair value
into three levels and bases the categorization within the hierarchy upon the lowest level of input that is available and significant to the fair value measurement:
Level 1 Quoted prices in active markets for identical assets or liabilities.
Level 2 Observable inputs other than quoted prices in active markets for identical assets and liabilities, quoted prices for identical or similar assets or liabilities in inactive markets,
or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.
Level 3 Inputs that are generally unobservable and typically reflect management s estimate of assumptions that market participants would use in pricing the asset or liability.
Note 2 Financial Instruments
Cash, Cash Equivalents and Marketable Securities
The following tables show the Company s cash and available-for-sale securities adjusted cost, gross unrealized gains, gross unrealized losses and fair value by significant investment category
recorded as cash and cash equivalents or short- and long-term marketable securities as of June 30, 2012 and September 24, 2011 (in millions):
June 30, 2012
Adjusted
Cost
Unrealized
Gains
Unrealized
Losses
Fair
Value
Cash and
Cash
Equivalents
Short-Term
Marketable
Securities
Long-Term
Marketable
Securities
Cash
3,269
3,269
3,269
Level 1:
Money market funds
1,181
1,181
1,181
Mutual funds
1,894
34
(17
1,911
1,911
Subtotal
3,075
34
(17
3,092
1,181
1,911
Level 2:
U.S. Treasury securities
20,587
10
(6
20,591
1,100
4,169
15,322
U.S. agency securities
19,197
41
(3
19,235
479
2,026
16,730
Non-U.S. government securities
6,919
103
(7
7,015
1,842
5,172
Certificates of deposit and time deposits
2,411
2,413
857
377
1,179
Commercial paper
2,301
2,301
991
1,310
Corporate securities
44,545
306
(31
44,820
24
7,482
37,314
Municipal securities
5,541
61
(3
5,599
43
588
4,968
Mortgage- and asset-backed securities
8,867
24
(5
8,886
8,882
Subtotal
110,368
547
(55
110,860
3,495
17,798
89,567
Total
116,712
581
(72
117,221
7,945
19,709
89,567
September 24, 2011
Adjusted
Cost
Unrealized
Gains
Unrealized
Losses
Fair
Value
Cash and
Cash
Equivalents
Short-Term
Marketable
Securities
Long-Term
Marketable
Securities
Cash
2,903
2,903
2,903
Level 1:
Money market funds
1,911
1,911
1,911
Mutual funds
1,227
(34
1,193
1,193
Subtotal
3,138
(34
3,104
1,911
1,193
Level 2:
U.S. Treasury securities
10,717
39
(3
10,753
1,250
2,149
7,354
U.S. agency securities
13,467
24
(3
13,488
225
1,818
11,445
Non-U.S. government securities
5,559
11
(2
5,568
551
1,548
3,469
Certificates of deposit and time deposits
4,175
(2
4,175
728
977
2,470
Commercial paper
2,853
2,853
2,237
616
Corporate securities
35,241
132
(114
35,259
10
7,241
28,008
Municipal securities
3,411
56
3,467
595
2,872
Subtotal
75,423
264
(124
75,563
5,001
14,944
55,618
Total
81,464
264
(158
81,570
9,815
16,137
55,618
The net unrealized gains as of June 30, 2012 and September 24, 2011 are related primarily to
long-term marketable securities. The Company may sell certain of its marketable securities prior to their stated maturities for strategic reasons including, but not limited to, anticipation of credit deterioration and duration management. The net
realized gains or losses recognized during the three- and nine-month periods ended June 30, 2012 and June 25, 2011 related to such sales were not significant. The maturities of the Company s long-term marketable securities generally
range from one to five years.
As of June 30, 2012 and September 24, 2011, gross unrealized losses related to
individual securities that had been in a continuous loss position for 12 months or longer were not significant.
As of
June 30, 2012, the Company considers the declines in market value of its marketable securities investment portfolio to be temporary in nature and does not consider any of its investments other-than-temporarily impaired. The Company typically
invests in highly-rated securities, and its investment policy generally limits the amount of credit exposure to any one issuer. The policy requires investments generally to be investment grade, with the primary objective of minimizing the potential
risk of principal loss. Fair values were determined for each individual security in the investment portfolio. When evaluating an investment for other-than-temporary impairment, the Company reviews factors such as the length of time and extent to
which fair value has been below its cost basis, the financial condition of the issuer and any changes thereto, and the Company s intent to sell, or whether it is more likely than not it will be required to sell the investment before recovery of
the investment s cost basis. During the three- and nine-month periods ended June 30, 2012 and June 25, 2011, the Company did not recognize any significant impairment charges.
Derivative Financial Instruments
The Company uses derivatives to partially
offset its business exposure to foreign currency exchange risk. The Company may enter into foreign currency forward and option contracts to offset some of the foreign exchange risk on expected future cash flows on certain forecasted revenue and cost
of sales, on net investments in certain foreign subsidiaries, and on certain existing assets and liabilities.
To help protect gross margins from fluctuations in foreign currency exchange rates, certain
of the Company s subsidiaries whose functional currency is the U.S. dollar hedge a portion of forecasted foreign currency revenue. The Company s subsidiaries whose functional currency is not the U.S. dollar and who sell in local currencies
may hedge a portion of forecasted inventory purchases not denominated in the subsidiaries functional currencies. The Company typically hedges portions of its forecasted foreign currency exposure associated with revenue and inventory purchases
generally up to six months.
To help protect the net investment in a foreign operation from adverse changes in foreign
currency exchange rates, the Company may enter into foreign currency forward and option contracts to offset the changes in the carrying amounts of these investments due to fluctuations in foreign currency exchange rates.
The Company may also enter into foreign currency forward and option contracts to partially offset the foreign currency exchange gains and
losses generated by the re-measurement of certain assets and liabilities denominated in non-functional currencies. However, the Company may choose not to hedge certain foreign currency exchange exposures for a variety of reasons including, but not
limited to, accounting considerations and the prohibitive economic cost of hedging particular exposures. There can be no assurance the hedges will offset more than a portion of the financial impact resulting from movements in foreign currency
exchange rates.
The Company records all derivatives in the Condensed Consolidated Balance Sheets at fair value. The
Company s accounting treatment of these instruments are based on whether the instruments are designated as hedge or non-hedge instruments. The effective portions of cash flow hedges are recorded in accumulated other comprehensive
income ( AOCI ) until the hedged item is recognized in earnings. The effective portions of net investment hedges are recorded in other comprehensive income as a part of the cumulative translation adjustment. The ineffective portions of
cash flow hedges and net investment hedges are recorded in other income and expense. Derivatives that are not designated as hedging instruments are adjusted to fair value through earnings in the financial statement line item to which the derivative
relates.
The Company had a net deferred gain associated with cash flow hedges of $201 million and $290 million, net of taxes,
recorded in AOCI as of June 30, 2012 and September 24, 2011, respectively. Deferred gains and losses associated with cash flow hedges of forecasted foreign currency revenue are recognized as a component of net sales in the same period as
the related revenue is recognized, and deferred gains and losses related to cash flow hedges of forecasted inventory purchases are recognized as a component of cost of sales in the same period as the related costs are recognized. Substantially all
of the Company s hedged transactions as of June 30, 2012 are expected to occur within six months.
Derivative
instruments designated as cash flow hedges must be de-designated as hedges when it is probable the forecasted hedged transaction will not occur in the initially identified time period or within a subsequent two-month time period. Deferred gains and
losses in AOCI associated with such derivative instruments are reclassified immediately into other income and expense. Any subsequent changes in fair value of such derivative instruments are reflected in other income and expense unless they are
re-designated as hedges of other transactions. The Company did not recognize any significant net gains or losses related to the loss of hedge designation on discontinued cash flow hedges during the three- and nine-month periods ended June 30,
2012 and June 25, 2011.
The Company s unrealized net gains and losses on net investment hedges, included in the
cumulative translation adjustment account of AOCI, were not significant as of June 30, 2012 and September 24, 2011, respectively. The ineffective portions of and amounts excluded from the effectiveness test of net investment hedges are
recorded in other income and expense.
During the three and nine-month periods ended June 30, 2012 and June 25,
2011, the gain/loss recognized in other income and expense for foreign currency forward and option contracts not designated as hedging instruments was not significant. These amounts represent the net gain or loss on the derivative contracts and do
not include changes in the related exposures, which generally offset a portion of the gain or loss on the derivative contracts.
The following table shows the notional principal amounts of the Company s outstanding
derivative instruments and credit risk amounts associated with outstanding or unsettled derivative instruments as of June 30, 2012 and September 24, 2011 (in millions):
June 30, 2012
September 24, 2011
Notional
Principal
Credit Risk
Amounts
Notional
Principal
Credit Risk
Amounts
Instruments designated as accounting hedges:
Foreign exchange contracts
33,892
569
13,705
537
Instruments not designated as accounting hedges:
Foreign exchange contracts
10,637
40
9,891
56
The notional principal amounts for outstanding derivative instruments provide one measure of the
transaction volume outstanding and does not represent the amount of the Company s exposure to credit or market loss. The credit risk amounts represent the Company s gross exposure to potential accounting loss on derivative instruments that
are outstanding or unsettled if all counterparties failed to perform according to the terms of the contract, based on then-current currency exchange rates at each respective date. The Company s gross exposure on these transactions may be
further mitigated by collateral received from certain counterparties. The Company s exposure to credit loss and market risk will vary over time as a function of currency exchange rates. Although the table above reflects the notional principal
and credit risk amounts of the Company s foreign exchange instruments, it does not reflect the gains or losses associated with the exposures and transactions that the foreign exchange instruments are intended to hedge. The amounts ultimately
realized upon settlement of these financial instruments, together with the gains and losses on the underlying exposures, will depend on actual market conditions during the remaining life of the instruments.
The Company generally enters into master netting arrangements, which reduce credit risk by permitting net settlement of transactions with
the same counterparty. To further limit credit risk, the Company generally enters into collateral security arrangements that provide for collateral to be received or posted when the net fair value of certain financial instruments fluctuates from
contractually established thresholds. The Company presents its derivative assets and derivative liabilities at their gross fair values. The Company received cash collateral related to the derivative instruments under its collateral security
arrangements of $492 million and $288 million as of June 30, 2012 and September 24, 2011, respectively. These amounts are classified as accrued expenses in the Condensed Consolidated Balance Sheets. The Company did not have any derivative
instruments with credit risk-related contingent features that would require it to post additional collateral as of June 30, 2012 or September 24, 2011.
The following tables show the Company s derivative instruments at gross fair value as reflected in the Condensed Consolidated Balance Sheets as of June 30, 2012 and September 24, 2011 (in
millions):
June 30, 2012
Fair Value of
Derivatives
Designated
as Hedge
Instruments
Fair Value
of
Derivatives
Not Designated
as Hedge
Instruments
Total
Fair Value
Derivative assets (a):
Foreign exchange contracts
548
40
588
Derivative liabilities (b):
Foreign exchange contracts
165
13
178
10
September 24, 2011
Fair Value of
Derivatives
Designated
as Hedge
Instruments
Fair Value of
Derivatives
Not Designated
as Hedge
Instruments
Total
Fair Value
Derivative assets (a):
Foreign exchange contracts
460
56
516
Derivative liabilities (b):
Foreign exchange contracts
72
37
109
(a)
The fair value of derivative assets is measured using Level 2 fair value inputs and is recorded as other current assets in the Condensed
Consolidated Balance Sheets.
(b)
The fair value of derivative liabilities is measured using Level 2 fair value inputs and is recorded as accrued expenses in the Condensed
Consolidated Balance Sheets.
The following tables show the pre-tax effect of the Company s derivative
instruments designated as cash flow and net investment hedges in the Condensed Consolidated Statements of Operations for the three- and nine-month periods ended June 30, 2012 and June 25, 2011 (in millions):